ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 20527 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 20527; 2) Community: the network communities that were significantly associated with the response to NSC 20527; 3) Molecule: the relationships between components within communities and NSC 20527; 4) MDR: the compounds that were significantly associated with the NSC 20527.

NSC Compound Enrichment Correlation
NSC 240419 Benzoic acid, 2-[[4-[bis(2-bromopropyl)amino]-2-methylphenyl]azo]- 0.00014759055644977 0.26544924
NSC 681646 Camptothecin Derivative 0.000217933685920728 0.10785609
NSC 630703 Acridomide 0.00057466710832899 0.12582164
NSC 720872 3-(3-Hydroxy-4-methoxybenzyl)-5,7-dihydroxychroman-4-one 0.00057466710832899 0.02930078
NSC 50686 Acna Naphthol T 0.000762764599619747 0.54820373
NSC 105014 Cladribine 0.00115116014164088 0.092852265
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.00115116014164088 -0.05117403
NSC 715974 Null 0.00115116014164088 0.44670152
NSC 721116 Null 0.00118765873091046 0.14918186
NSC 756998 1-[(4-aminophenyl)-(4-hydroxyphenyl)methylidene]-[3]ferrocenophane 0.00118765873091046 0.20187717
Total:36  Current:1    [First] [Prev] [Next] [Last]